There are a number of positive catalysts on the horizon for Endeavour Mining PLC, according to analysts at Barclays who reiterated that the stock remains its preferred precious metals equity exposure in Europe.
In a note to clients, the analysts highlighted that on May 11, it was revealed that the West Africa-focused gold miner would be included in the MSCI Standard Development Market indices, with the rebalance effective after the market close on May 31.
Sintana Energy (TSX-V:SEI, OTCQB:SEUSF) Inc revealed that one of its Namibian affiliates, Custos Investments Pty Limited, has wrapped up a 6,593 square kilometer 3D seismic acquisition program over and around Petroleum Exploration License 87 (PEL 87) in the highly prospective Orange Basin, off the coast of Namibia.
The Toronto-based petroleum and natural gas explorer said the finished seismic acquisition program exceeds the initially planned area by over 1,500 square kilometers. Initial acquisition results signal a “high-quality dataset” can be expected, noted Sintana.
Century Lithium Corp. (TSX-V:LCE, OTCQX:CYDVF) said it has repeated the production of high-purity lithium carbonate grading 99.87% using lithium-bearing claystone from its Clayton Valley lithium project in Nevada.
"These results are in line with those we reported in September 2022, when we achieved a significant milestone in making lithium carbonate grading 99.94%," said Century Lithium CEO Bill Willoughby in a statement.
Kootenay Silver Inc said it has closed its previously announced brokered private placement offering for gross proceeds of approximately $2.1 million with a non-brokered portion for gross proceeds of approximately $1.6 million, at a price of 10 cents per unit, giving aggregate gross proceeds of $3,772,500.
Biocept Inc has announced the pricing of an underwritten public offering to raise gross proceeds of approximately $5 million. The offering is for 1,176,470 shares of its common stock and warrants to purchase up to an aggregate of 2,352,940 shares of its common stock at a combined offering price of $4.25 per share (or pre-funded warrant in lieu thereof) and an accompanying warrant to purchase two shares of common stock. The warrants will have a per share exercise price of $4.25, are exercisable immediately, will expire five years from the date of issuance and contain an alternative cashless exercise provision whereby, subject to certain conditions. Biocept expects to use the net proceeds from the offering for the advancement of its FORESEE trial for CNSide, working capital and general corporate purposes.
Electra Battery Materials Corp said that Garett Macdonald has resigned as a member of the company’s board of directors to devote more time to his growing responsibilities as chief executive officer of Maritime Resources Corp. "On behalf of the board of directors, I would like to thank Garett for his many contributions to Electra over the past five years and extend him best wishes for continued success," said John Pollesel, Electra's chairman. "Current directors and I remain fully committed to achieving Electra's vision and we are actively supporting management's efforts to address the funding shortfall needed to complete the construction of our refinery project. We anticipate providing an update on our progress in the coming weeks."
Mandalay Resources Corp has announced the results of its Annual and Special General Meeting of Shareholders held virtually on Wednesday, May 24, 2023. All the resolutions presented at the meeting were approved by the shareholders, with the votes cast by proxy representing 75.67% of the total shares outstanding as of the record date.
Tiziana Life Sciences Ltd has announced that it will host a virtual KOL event to discuss the potential of foralumab in non-active secondary progressive multiple sclerosis (na SPMS) on Monday, June 5, 2023, at 12.30pm ET. The event will feature Dr Howard Weiner, co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital, a founding member of Mass General Brigham Healthcare System), who will discuss anti-inflammatory approaches in treating neurodegenerative disease and will include an update on the ongoing intranasal foralumab Expanded Access Program in non-active secondary progressive multiple sclerosis (na SPMS). A live question and answer session will follow the formal presentations. To register for the event, interested parties can use the following link: https://lifescievents.com/event/tiziana/
Quantum eMotion said its Annual General Meeting (AGM) will be held on 15 June 2023, at 9.00am Montreal time in both in-person and virtual format. The meeting will take place at 1, Place Ville Marie, 40th Floor, Montreal, Quebec, and online via live webcast at: https://lavery.zoom.us/j/65649686965.